Base to Base biotech podcast 68: Water from air for pharma and beyond
New phase 1 data show potential for neurodegenerative disease treatment
Metabolic syndrome linked to faster brain ageing
Bowel cancer samples could boost understanding of other killer diseases
Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
CIRM approves $100m plan to accelerate genetic therapies for patients with rare diseases
Researchers develop more reliable platform to test antibody medicines
Positive topline results from acne study
Sarbecovirus vaccine trial starts